StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.73+0.02 (+0.05%)

Close on Nov 18, 2026Market cap $27.98BP/E –Yield –

Roivant Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Roivant Sciences's revenue for the twelve months ending Jun 30, 2026 was $7.53M, down 67.6% year over year. For fiscal 2025 it was $8.26M, down 71.6% from the year before. The highest annual figure on record is $55.29M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Mar 31, 2026$8.26M-71.6%
FY2024Mar 31, 2025$29.05M-11.2%
FY2023Mar 31, 2024$32.71M+3.8%
FY2022Mar 31, 2023$31.53M-43.0%
FY2021Mar 31, 2022$55.29M+132.3%
FY2020Mar 31, 2021$23.80M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2026CQ2 2026Jun 30, 2026$1.44M-33.5%
Q4 FY2025CQ1 2026Mar 31, 2026$2.52M-66.7%
Q3 FY2025CQ4 2025Dec 31, 2025$2.00M-77.8%
Q2 FY2025CQ3 2025Sep 30, 2025$1.57M-64.9%
Q1 FY2025CQ2 2025Jun 30, 2025$2.17M-72.8%
Q4 FY2024CQ1 2025Mar 31, 2025$7.57M-16.1%
Q3 FY2024CQ4 2024Dec 31, 2024$9.02M-42.1%
Q2 FY2024CQ3 2024Sep 30, 2024$4.48M+22.7%
Q1 FY2024CQ2 2024Jun 30, 2024$7.99M-63.1%
Q4 FY2023CQ1 2024Mar 31, 2024$9.02M-67.1%
Q3 FY2023CQ4 2023Dec 31, 2023$15.56M-8.7%
Q2 FY2023CQ3 2023Sep 30, 2023$3.65M-70.9%
Q1 FY2023CQ2 2023Jun 30, 2023$21.62M+400.7%
Q4 FY2022CQ1 2023Mar 31, 2023$27.38M+196.8%
Q3 FY2022CQ4 2022Dec 31, 2022$17.05M-29.9%
Q2 FY2022CQ3 2022Sep 30, 2022$12.53M-10.4%
Q1 FY2022CQ2 2022Jun 30, 2022$4.32M-44.2%
Q4 FY2021CQ1 2022Mar 31, 2022$9.22M-39.1%
Q3 FY2021CQ4 2021Dec 31, 2021$24.34M+323.3%
Q2 FY2021CQ3 2021Sep 30, 2021$13.99M+957.2%
Q1 FY2021CQ2 2021Jun 30, 2021$7.74M+390.8%
Q4 FY2020CQ1 2021Mar 31, 2021$15.15M–
Q3 FY2020CQ4 2020Dec 31, 2020$5.75M–
Q2 FY2020CQ3 2020Sep 30, 2020$1.32M–
Q1 FY2020CQ2 2020Jun 30, 2020$1.58M–

More Roivant Sciences figures

See a number that looks wrong?